Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Adesso BioProducts AB

Closing information (x1000 DKK)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 1,122,088 More Arrow 1,788,602 More Arrow 1,822,902
Financial expenses 4,588 More Arrow 11,155 Less Arrow 7,361
Earnings before taxes 120,458 More Arrow 138,450 Less Arrow 112,064
EBITDA 119,431 More Arrow 146,206 Less Arrow 120,180
Total assets 569,088 Less Arrow 555,950 More Arrow 603,073
Current assets 557,757 Less Arrow 544,629 More Arrow 591,195
Current liabilities 111,186 More Arrow 163,656 More Arrow 216,886
Equity capital 405,946 Less Arrow 338,560 Less Arrow 296,242
- share capital 65 More Arrow 67 Equal arrow 67
Employees (average) 22 More Arrow 24 Less Arrow 21

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 71.3% Less Arrow 60.9% Less Arrow 49.1%
Turnover per employee 51,004 More Arrow 74,525 More Arrow 86,805
Profit as a percentage of turnover 10.7% Less Arrow 7.7% Less Arrow 6.1%
Return on assets (ROA) 22.0% More Arrow 26.9% Less Arrow 19.8%
Current ratio 501.6% Less Arrow 332.8% Less Arrow 272.6%
Return on equity (ROE) 29.7% More Arrow 40.9% Less Arrow 37.8%
Change turnover -607,354 More Arrow -43,688 More Arrow 151,019
Change turnover % -35% More Arrow -2% More Arrow 9%
Chg. No. of employees -2 More Arrow 3 Less Arrow 0
Chg. No. of employees % -8% More Arrow 14% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.